A 16-year-old man was transferred to our emergency department seven hours after ingesting 486 aspirin tablets. His blood salicylate level was 83.7 mg/dL. He was treated with fluid resuscitation and sodium bicarbonate infusion, and his condition gradually improved, with a decline in the blood salicylate level. However, eight days after admission, he again reported nausea, a venous blood gas revealed metabolic acidosis with a normal anion gap. The blood salicylate level was undetectable, and a urinalysis showed glycosuria, proteinuria and elevated beta-2 microglobulin and n-acetyl glucosamine levels, with a normal urinary pH despite the acidosis. We diagnosed him with relapse of metabolic acidosis caused by renal tubular acidosis.
Introduction
Acute salicylate poisoning is common, and metabolic acidosis with an increased anion gap is a well-known feature of salicylate poisoning. We herein describe a case of acute salicylate poisoning that progressed to renal tubular acidosis (RTA) eight days after ingestion, presenting as relapse of metabolic acidosis without an increased anion gap.
Case Report
A 16-year-old man was transferred to a local hospital four hours after ingesting 486 aspirin tablets (330 mg tablets) in a suicide attempt. He did not have diabetes or renal failure. He complained of nausea and frequent vomiting and was tachypneic. The laboratory findings showed the following data: Na 141 mEq/L, K 3.3 mEq/L, Cl 101 mEq/L, pH 7.523, arterial pO2 108.5 mmHg, pCO2 21.6 mmHg, HCO3 17.4 mEq/L and base excess -2.9 mEq/L. Therefore, an acid base disturbance with respiratory alkalosis was diagnosed secondary to acute salicylate toxicity, and he was managed with intravenous fluids, sodium bicarbonate (NaHCO3), gas-tric lavage and activated charcoal via a gastric tube.
The patient was subsequently referred to our emergency department for further treatment, where he was seen seven hours after ingestion, at which point he was sleepy and diaphoretic. His vital signs revealed a heart rate of 116 beats/ min, blood pressure of 97/54 mmHg, respiratory rate of 23 breaths/min, body temperature of 37.2 and oxygen saturation of 97% on room air. The initial laboratory values were as follows: white blood cell count 14.5×10 9 /L, hemoglobin 169 g/L, platelet count 770×10 9 /L, Na 144 mEq/L, K 3.5 mEq/L, Cl 95 mEq/L, blood urea nitrogen (BUN) 12.4 mg/ dL, creatinine 1.05 mg/dL and random glucose 122 mg/dL. An arterial blood gas analysis showed respiratory alkalosis (pH 7.526, arterial pO2 111.4 mmHg, pCO2 31.8 mmHg, HCO3 25.7 mEq/L, base excess 3.8 mEq/L and an elevated anion gap at 23.3), and a urinalysis showed glycosuria, proteinuria and ketonuria. Upon arrival (7 hours after ingestion), the blood salicylate level was 83.7 mg/dL, and hemodialysis was not performed. He was treated with fluid resuscitation and NaHCO3 infusion (approximately 300 mEq/ day), and his condition gradually improved, with a decline in the blood salicylate level (Figure) . On the fourth day of admission, he was asymptomatic and the bicarbonate ther- The PCO2 level seemed to be relatively high in the presence of the low bicarbonate level; therefore, we consider this finding to be a measurement error on the venous blood gas analysis, as he did not show respiratory failure at that time. Furthermore, the blood salicylate level was undetectable (<0.1 μg/mL), whereas the serum potassium and phosphate levels were within the normal limits (K 4.1 mEq/L, Cl 107 mEq/L). A urinalysis showed glycosuria, proteinuria, elevated beta-2 microglobulin (31.75 mg/L) and n-acetyl glucosamine (15.4 U/L) levels and a urinary pH of 6.5, despite the metabolic acidosis. These symptoms, together with the absence of further salicylate elevation, suggested renal tubular dysfunction (Table) . We therefore considered that the relapse of metabolic acidosis was caused by RTA. The patient gradually recovered with intravenous bicarbonate therapy (approximately 300 mEq per day), which was discontinued 18 days after admission and replaced with oral bicarbonate therapy (3 g per day). He was discharged 26 days after admission. At the follow-up visit two weeks later, he was asymptomatic. Additionally, a urinalysis showed no glycosuria and minimal proteinuria, and his renal function had normalized (BUN 13.0 mg/dL and creatinine 0.98 mg/dL).
Discussion
Salicylate overdoses are commonly encountered in the emergency department. Although the overall mortality rate of salicylate poisoning is low, metabolic acidosis, convulsions, coma, hyperpyrexia, pulmonary edema, renal failure and death occur in 5% of severe cases (1). Salicylate toxic-ity initially causes respiratory alkalosis because of a stimulatory effect on the respiratory center. Anion gap metabolic acidosis then follows because of accumulation of lactic acid and ketones (2) . The course of the present case was consistent with this description, initially presenting as an acid-base disturbance with an elevated anion gap. Respiratory alkalosis was also present based on the salicylate level. This type of mixed acid-base disturbance is characteristic of acute severe salicylate poisoning (2, 3) .
Despite successfully treating the initial acid-base disturbance in this case, relapse occurred on the eighth day of admission. The late-onset acidosis had characteristics different from the initial mixed acid-base disturbance, in that it presented with a normal anion gap without an elevated salicylate level. Previous case reports have described delayed presentations of metabolic acidosis in patients with acute salicylate poisoning (4-6). However, the delayed toxicities in these cases were explained by delayed absorption caused by the enteric coating on the drug for sustained release (5) or bezoar formation (6) . In the current case, the delayed toxicity could not be explained by delayed salicylate absorption because the salicylate level remained undetectable.
At the time of recurrence of metabolic acidosis, a urinalysis showed glycosuria, proteinuria and elevation of β-2 microglobulin and n-acetyl glucosamine, with a urinary pH of 6.5 despite metabolic acidosis. These findings strongly suggested the presence of proximal tubular injury and impaired acidification of the urine. RTA is characterized by a defect in the ability of the renal tubules to maintain a normal acidbase status and is accompanied by metabolic acidosis with a normal anion gap (3) . Therefore, we considered that the relapse of metabolic acidosis in this patient was due to RTA. Furthermore, glycosuria had already been reported seven hours after ingestion, and there is a possibility that renal tubular acidosis may progress insidiously, as became apparent following the discontinuation of bicarbonate therapy. Clinical reports of RTA caused by acute salicylate poisoning are rare. To our knowledge, only one such report has previously been published, which concerned a 17-year-old patient presenting with renal tubular dysfunction, similar to that seen in Fanconi syndrome (7) . However, RTA can be caused by various drugs, including non-steroidal anti-inflammatory drugs (3). Salicylate-induced proximal tubular dysfunction is also reported to occur in animals and usually develops within few hours after administration (8) . Therefore, it is possible that the occurrence of RTA in cases of acute salicylate poisoning is under-reported. Clinicians should therefore consider the possibility of RTA in patients with salicylate poisoning who display acid-base disturbances, especially in cases involving late-onset metabolic acidosis and a normal anion gap.
We herein reported a case of successful treatment of metabolic acidosis due to salicylate poisoning, which relapsed with late-onset normal anion gap metabolic acidosis and an undetectable serum salicylate level. Physicians should consider the possibility of RTA when patients develop late-onset metabolic acidosis following acute salicylate poisoning.
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